Clinical Trial

Transcutaneous Auricular Vagus Nerve Stimulation for Treating Post-stroke Dysphagia

Study acronym: LOGIC
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 14, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
The aim of the present project is to use transcutaneous auricular vagus nerve stimulation (t-VNS) for the treatment of dysphagia in acute stroke patients to improve swallowing function and reduce mortality and disability related to this condition. 30 patients will be randomized into one of the two arms of the study: * REAL: real t-VNS + speech therapy * SHAM: t-VNS placebo + speech therapy. The experimental treatment consists in the association between t-VNS (real or placebo) and speech therapy exercises to improve swallowing functionality. Each patient will undergo a speech therapy rehabilitation session lasting approximately 40 minutes a day for 3 consecutive days, simultaneously with t-VNS on left ear. Swallowing function and clinical conditions will be evaluated before the intervention (baseline, T0), immediately after the intervention (T1) and 3 months after the intervention (T2).
Trial Details
NCT Number NCT06827301
Lead Sponsor Campus Bio-Medico University
Conditions Dysphagia Following Cerebrovascular Accident
Enrollment 30 participants
Start Date 2024-11-23
Primary Completion 2025-12 (estimated)
Study Completion 2026-06 (estimated)
Updated on ClinicalTrials.gov 2025-02-14